What If a Liver Hemangioma Is Indeterminate or Atypical?
At a Glance
An indeterminate or atypical liver hemangioma does not automatically mean cancer. Doctors usually review the scans, consider liver health and cancer history, and use contrast MRI, CT, or ultrasound with follow-up; biopsy is rarely needed.
If your scan report describes a suspected liver hemangioma as “indeterminate” or “atypical,” it means the available images did not capture the classic features needed for a confident diagnosis. It does not automatically mean you have cancer or need an immediate operation. In one large multicenter study, over 93% of liver lesions labeled as “atypical hemangiomas” turned out to be completely benign [1]. However, because individual risks vary—especially for those with underlying liver disease or a history of cancer—a structured follow-up is necessary to find out exactly what the lesion is.
Why Do Hemangiomas Look Atypical?
The appearance of a hemangioma depends on the imaging method and the mass itself.
- Limitations of the first scan: If your first test was a standard ultrasound without contrast dye, it is often not enough to definitively diagnose a hemangioma [2].
- Internal changes: Over time, some hemangiomas develop internal scar tissue (a condition known as a sclerosing hemangioma) or undergo other structural changes [3]. This alters how blood flows through the mass and how it absorbs contrast dye, making it look different from a textbook hemangioma.
The Step-by-Step Evaluation Process
When a liver lesion is indeterminate, your medical team will typically follow a systematic approach to safely determine what it is without rushing into unnecessary procedures.
1. Expert Review and Clinical Context
A radiologist specializing in abdominal imaging should review your original scans [4]. Your doctor will also look closely at your medical history. An indeterminate lesion in someone with a healthy liver is viewed differently than a new lesion in someone with a history of cancer, cirrhosis (severe liver scarring), or chronic liver disease, which inherently raises the risk profile [5][6].
2. Advanced Contrast Imaging
If the first scan was inconclusive, you will likely need a more detailed scan using intravenous contrast dye (a substance that highlights blood vessels). These are often multiphasic scans, meaning they take pictures at multiple different phases of blood flow to watch how the dye enters and exits the lesion over time.
| Imaging Test | How it Works | Key Considerations |
|---|---|---|
| Multiphasic MRI | Uses strong magnets and radio waves (no radiation). Often the preferred test for characterizing liver lesions [7][8]. | Highly detailed. Requires checking for metal implants (though many modern pacemakers are now MRI-conditional). Can be difficult for severe claustrophobia. |
| Multiphasic CT | Uses X-rays to create cross-sectional images [8]. | Faster than MRI. Uses ionizing radiation and iodine-based contrast (requires checking kidney function and allergies). |
| Contrast-Enhanced Ultrasound (CEUS) | Uses standard ultrasound combined with microscopic bubbles as a contrast agent [9][2]. | No radiation. Excellent for watching blood flow in real-time. A great problem-solving tool if MRI or CT are unclear [10]. |
Safety Note: Always tell your care team about pregnancy, kidney disease, implants, prior contrast reactions, and all medications you take before scheduling imaging.
3. What If Advanced Scans Are Still Unclear?
If high-quality advanced imaging still leaves the diagnosis uncertain, your doctor has several options:
- Multidisciplinary Tumor Board (MDT): Your case may be referred to a specialized team of liver experts—including hepatologists (liver doctors), radiologists, surgeons, and oncologists. Do not let the name frighten you; this review is for diagnostically complex cases to ensure the safest, most accurate care, not because they assume you have cancer [7][4].
- Planned Follow-up Imaging: Your care team might recommend repeating the scan after a specific interval (e.g., a few months) [11][1]. The timing is highly individualized based on your risk factors. While short-term stability does not guarantee a lesion is benign, a mass that remains stable in size and appearance over time strongly supports a benign diagnosis. If it is eventually confirmed as a typical hemangioma, you may not need further imaging.
- Liver Biopsy: A biopsy (using a needle to take a small tissue sample) is rarely required and is generally avoided for vascular (blood vessel-rich) tumors like hemangiomas due to the risk of internal bleeding [2][12]. It is only considered if advanced imaging cannot rule out cancer and the tissue result will directly change your treatment plan [13][14]. Important: If a biopsy is recommended, never stop, skip, or change taking blood thinners or aspirin on your own. Your doctor will give you specific, safe instructions on managing your medications.
- Surgical Consultation: Referral to an experienced liver surgeon is uncommon. Surgery is generally reserved for cases where malignancy cannot be safely excluded, or if the hemangioma is causing complications (like a rupture) or persistent severe symptoms directly attributable to the mass [4][15]. Size or slow growth alone does not automatically require surgery.
When to Seek Urgent Care
Serious complications from liver hemangiomas are rare. However, you should seek immediate emergency medical care if you experience sudden severe upper abdominal pain, fainting, marked dizziness, or signs of internal bleeding.
Common questions in this guide
What does it mean when a liver hemangioma is called indeterminate or atypical?
Could an atypical liver hemangioma be cancer?
Which scan can clarify an indeterminate liver lesion?
What happens if MRI or CT still cannot identify the lesion?
Should I stop aspirin or blood thinners before a possible liver biopsy?
When should I seek emergency care for a liver hemangioma?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Did a radiologist specializing in abdominal imaging review my original scans?
- 2.Which type of advanced contrast imaging (MRI, CT, or CEUS) do you recommend for my specific situation and why?
- 3.Given my personal medical history, what is the likelihood that this lesion is something other than a benign hemangioma?
- 4.Will my case be reviewed by a multidisciplinary liver tumor board to ensure all expert opinions are considered?
- 5.If we monitor the lesion with interval imaging, when exactly should my next scan be scheduled, and what changes are we looking for?
- 6.If this lesion is eventually confirmed to be a typical hemangioma, will I be able to stop routine follow-up imaging?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (15)
- 1
Use of the Term "Atypical Hepatic Hemangioma" in Radiology Reports: An Analysis of Diagnostic Precision.
Tamir S, Krutik T, Kedem Mashraki R, et al.
Journal of clinical medicine 2026; (15(15)) doi:10.3390/jcm15155923.
PMID: 42590025 - 2
One stop shop approach for the diagnosis of liver hemangioma.
Sandulescu LD, Urhut CM, Sandulescu SM, et al.
World journal of hepatology 2021; (13(12)):1892-1908 doi:10.4254/wjh.v13.i12.1892.
PMID: 35069996 - 3
Hepatic sclerosed hemangioma and sclerosing cavernous hemangioma: a radiological study.
Jia C, Liu G, Wang X, et al.
Japanese journal of radiology 2021; (39(11)):1059-1068 doi:10.1007/s11604-021-01139-z.
PMID: 34041675 - 4
Multiple hepatic sclerosing hemangiomas mimicking malignant lesions, a diagnostic dilemma: case report and literature review.
Al Baali DM, Ajoub MM, Al Qarshoubi IS, et al.
Diagnosis (Berlin, Germany) 2026; (13(2)):332-339 doi:10.1515/dx-2025-0078.
PMID: 41047826 - 5
Vascular phases in imaging and their role in focal liver lesions assessment.
Chiorean L, Caraiani C, Radziņa M, et al.
Clinical hemorheology and microcirculation 2015; (62(4)):299-326 doi:10.3233/CH-151971.
PMID: 26444602 - 6
WFUMB Review Paper. Incidental Findings in Otherwise Healthy Subjects, How to Manage: Liver.
Șirli R, Popescu A, Jenssen C, et al.
Cancers 2024; (16(16)) doi:10.3390/cancers16162908.
PMID: 39199678 - 7
Approach to the Solitary Liver Lesion: Imaging and When to Biopsy.
Pang EH, Harris AC, Chang SD
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2016; (67(2)):130-48.
PMID: 26702758 - 8
Indeterminate liver lesions on gadoxetic acid-enhanced magnetic resonance imaging of the liver: Case-based radiologic-pathologic review.
Noreikaite J, Albasha D, Chidambaram V, et al.
World journal of hepatology 2021; (13(9)):1079-1097 doi:10.4254/wjh.v13.i9.1079.
PMID: 34630876 - 9
Contrast-Enhanced Ultrasound of Focal Liver Lesions.
D'Onofrio M, Crosara S, De Robertis R, et al.
AJR. American journal of roentgenology 2015; (205(1)):W56-66 doi:10.2214/AJR.14.14203.
PMID: 26102419 - 10
Characterization of Indeterminate Liver Lesions on CT and MRI With Contrast-Enhanced Ultrasound: What Is the Evidence?
Wang DC, Jang HJ, Kim TK
AJR. American journal of roentgenology 2020; (214(6)):1295-1304 doi:10.2214/AJR.19.21498.
PMID: 32182094 - 11
Diagnosis and Follow-up of Incidental Liver Lesions in Children.
Karmazyn B, Rao GS, Johnstone LS, et al.
Journal of pediatric gastroenterology and nutrition 2022; (74(3)):320-327 doi:10.1097/MPG.0000000000003377.
PMID: 34984985 - 12
Case report: A rare immune-related adverse effect: hepatic cavernous hemangioma induced by camrelizumab.
Zhang C, Wang G, Liu N, et al.
Frontiers in immunology 2024; (15()):1387465 doi:10.3389/fimmu.2024.1387465.
PMID: 38646529 - 13
Atypical hemangioma mimicking mixed hepatocellular cholangiocarcinoma: Case report.
Lin S, Zhang L, Li M, et al.
Medicine 2017; (96(50)):e9192 doi:10.1097/MD.0000000000009192.
PMID: 29390333 - 14
Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology.
Neuberger J, Patel J, Caldwell H, et al.
Gut 2020; (69(8)):1382-1403 doi:10.1136/gutjnl-2020-321299.
PMID: 32467090 - 15
Proposal of size-based surgical indication criteria for liver hemangioma based on a nationwide survey in Japan.
Sakamoto Y, Kokudo N, Watadani T, et al.
Journal of hepato-biliary-pancreatic sciences 2017; (24(7)):417-425 doi:10.1002/jhbp.464.
PMID: 28516570
This page explains how indeterminate or atypical liver hemangioma findings are commonly evaluated for informational purposes only and does not constitute medical advice. Your radiologist and treating clinician should interpret your scans and recommend follow-up or procedures.
Get notified when new evidence is published on liver hemangioma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.